Tag
NASDAQ: BIAF
- bioAffinity Technologies grows lung-test sales but flags funding needs
- bioAffinity Technologies reports more than 1,620 CyPath Lung tests
- bioAffinity launches 2,000‑patient study for noninvasive lung cancer test
- Lung cancer awareness month: a Mugglehead roundup
- bioAffinity Technologies shines After CyPath Lung Clinical case studies